Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000935
Chunk: 28

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 28
---
 similar plan or agreement. The Company
has furnished or made available (provided that any documents filed with the SEC and available on the SEC’s EDGAR system shall be
deemed to have been made available) to the Investor true and correct copies of the Company’s Articles of Association, as in effect
on the Execution Date (the “”), and summaries of the material terms of all securities convertible
into or exercisable for Ordinary Shares (including Ordinary Shares represented by Depositary Shares), if any, and copies of any documents
containing the material rights of the holders thereof in respect thereto that are not disclosed in the SEC Documents.

| -13- |

(d) . Upon the allotment and payment therefor in accordance with the terms and conditions of this Agreement, the Purchase
Shares shall be validly issued, fully paid and nonassessable and free from all taxes, liens, charges, restrictions, rights of first refusal
and preemptive rights with respect to the issue thereof imposed by the Company, with the holders being entitled to all rights accorded
to a holder of Depositary Shares. Upon the allotment in accordance with the terms and conditions of this Agreement, the Commitment Shares
(as defined in ), if any, shall be validly issued, fully paid and nonassessable and free from all taxes, liens, charges,
restrictions, rights of first refusal and preemptive rights with respect to the issue thereof imposed by the Company, with the holders
being entitled to all rights accorded to a holder of Depositary Shares.

(e) . The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the Company
of the transactions contemplated hereby and thereby (including, without limitation, the allotment of the Purchase Shares and, if applicable,
the Commitment Shares) will not (i) result in a violation of the Articles of Association or (ii) conflict with, or constitute a default
(or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment,
acceleration or cancellation of, any agreement, indenture or instrument to which the Company or any of its Subsidiaries is a party, or
result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations,
the rules of the Principal Market applicable to the Company or any of its Subsidiaries) or by which any property or asset